Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...
Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...
Weight loss drugs like Ozempic deliver more health benefits than expected.
Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.
G LP-1 drugs containing semaglutide (the active ingredient in Ozempic and Wegovy) have exploded in popularity for their ...
Longevity doctor reveals common Ozempic mistakes affecting adults over 50, including protein deficiency, mental health risks, and muscle loss. Learn proper usage.
Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.
Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...
With semaglutide shortages in the rearview, Novo Nordisk is doubling down on marketing efforts for its GLP-1 drugs.
As the global demand for obesity treatments skyrockets, Vikrant Shrotriya discusses the complex nature of obesity, the ...
State DHS officials say new weight-loss drugs are driving up costs for Pennsylvania’s Medicaid program, likely leading to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results